Shares of Regeneron Pharmaceuticals, Inc. (REGN) are falling about 6 percent during Wednesday morning trading, after the company announced a decline in its first-quarter earnings to $727.2 million, or $6.75 per share, from last year's $808.7 million, or $7.27 per share.
The company's stock is currently trading at $683.59, down 6.58 percent or $48.18, over the previous close of $731.77 on the Nasdaq. It has traded between $476.49 and $821.11 in the past one year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.